HIVTx_24_Theme_Banner_Web_v1

PART 1 MODULES 1 & 2  ALL NEW UPDATES!

Wednesday, July 17th 2024 at 12:00 pm EDT

Speaker: 

Kwakwa, Helena

Helena Kwakwa, MD, MPH
Director HIV Clinical Services
Philadelphia Department of Public Health
Ambulatory Health Services
Philadelphia, Pennsylvania

     

     
Scoll down to access the program LOG-IN window at the bottom of this page!
 

Target Audience

This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.

 

Learning Objectives

Upon completion of theactivity, participants should be better able to: 

• Describe and address risk factors that contribute to the continued spread of HIV, especially in high-risk and underserved population

• Review the need for strategies to reduce the risk of new infections with HIV in various populations

• Explain the rationale behind various behavioral and medical interventions designed to improve linkage to HIV care and improve treatment outcomes

• Identify and address barriers to optimal HIV treatment in various populations, including STI, PWID, and underserved populations

 

Joint Accreditation Statement:

Jointly-Accredited-Provider-TM_1000x636 In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and ViralEd, Inc. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team  


Physician Continuing Medical Education:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosure of Conflicts of Interest 

Postgraduate Institute for Medicine (PIM) requires faculty, planners and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

 

Tony Urbina, MD

  • Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Gilead, Janssen, Viiv.

 

Postgraduate Institute for Medicine

The PIM planners and others have nothing to disclose.  The ViralEd, Inc. planners and others have nothing to disclose.  

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

 

 

FILL OUT THE FORM BELOW TO JOIN OUR PROGRAM

 

HIV Treatment and Prevention: Optimizing HIV Treatment and Prevention in STI, PWID and Underserved Populations. Part 1 Modules 1 & 2
Your name *
Email address *
Degree/Profession *
Country *
How many participants are watching using your internet connection? *
 
* Required